Matt S. Anderson

Antibacterial Agents That Inhibit Lipid A Biosynthesis

Hiroshi Ōnishi, Barbara A. Pelak, Lynn S. Gerckens et al. · Science · 1996 · 410 citations

Life Sciences, Microbiology, Pharmacology +15

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Rajesh Krishna, Matt S. Anderson, Arthur Bergman et al. · The Lancet · 2007 · 277 citations

Life Sciences, Pharmacology, Pharmacotherapy +15

The envA Permeability/Cell Division Gene of Escherichia coli Encodes the Second Enzyme of Lipid A Biosynthesis

Katherine Young, Lynn L. Silver, David Bramhill et al. · Journal of Biological Chemistry · 1995 · 192 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15

Biosynthesis of lipid A precursors in Escherichia coli. A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine.

Matt S. Anderson, C R Raetz · Journal of Biological Chemistry · 1987 · 185 citations · Full text

Life Sciences, Biochemistry, Microbiology +16

UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable.

Matt S. Anderson, Herbert G. Bull, Susan Galloway et al. · Journal of Biological Chemistry · 1993 · 158 citations · Full text

Life Sciences, Biochemistry, Microbiology +15